RBC Capital Maintains Sector Perform on Hologic, Lowers Price Target to $77
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Conor McNamara has maintained a 'Sector Perform' rating on Hologic (NASDAQ:HOLX) but lowered the price target from $81 to $77.
October 05, 2023 | 4:04 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
RBC Capital has maintained its 'Sector Perform' rating on Hologic but lowered the price target from $81 to $77, which may impact investor sentiment.
The lowering of the price target by RBC Capital indicates a less optimistic outlook for Hologic, which could negatively impact the stock's price in the short term. However, the maintenance of the 'Sector Perform' rating suggests that the company is still expected to perform on par with other companies in the sector.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100